1. Short title This Act may be cited as the Fixing Administrations Unethical Corrupt Influence Act or the FAUCI Act . 2. Prohibition against service by former employees of covered health agencies on boards of entities involved in development and research of a drug, biological product, or device (a) Prohibition against service on boards of entities Title 18, United States Code, is amended by inserting after section 207 the following: 207A. Prohibition against service by former employees of covered health agencies on boards of entities involved in development and research of a drug, biological product, or device (a) Definitions In this section: (1) Biological product The term biological product has the meaning given such term in section 351(i) of the Public Health Service Act ( 42 U.S.C. 262(i) ). (2) Covered health agency The term covered health agency means any of the following: (A) The National Institutes of Health. (B) The Food and Drug Administration. (C) The Centers for Disease Control and Prevention. (3) Device; drug The terms device and drug have the meanings given those terms in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). (4) Top official The term top official means— (A) any officer or employee in the executive branch who occupies a position classified at or above GS–13 of the General Schedule or, in the case of any position not under the General Schedule, for which the rate of basic pay is equal to or greater than the minimum rate of basic pay payable for GS–13 of the General Schedule